BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The Milner Therapeutics Institute - ECPv6.15.19//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.milner.cam.ac.uk
X-WR-CALDESC:Events for The Milner Therapeutics Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210610T120000
DTEND;TZID=UTC:20210610T130000
DTSTAMP:20260411T075849
CREATED:20210518T104356Z
LAST-MODIFIED:20210716T095619Z
UID:7761-1623326400-1623330000@www.milner.cam.ac.uk
SUMMARY:CATS-Milner Therapeutic Perspectives Series: Translating breakthroughs in Alzheimer’s Disease into new treatments
DESCRIPTION:The CATS-Milner Therapeutic Perspectives Series is a new panel event that provides expert opinion and thought-provoking discussion around key challenges in translational research. It is aimed at a mixed academic-industry audience and draws on expert speakers from across academia\, industry\, medicine\, investors\, policy and funding. \nOur first event will focus on experimental breakthroughs and challenges in research into this neurodegenerative disease\, key gaps and how to best create the right environment to support new treatments. \nChair:\nJohn Skidmore (Chief Scientific Officer\, ALBORADA Drug Discovery Institute funded by Alzheimer’s Research UK) \nPanel speakers:\nDavid Rubinsztein\, Cambridge Institute for Medical Research\, University of Cambridge\nJames Rowe\, MRC Cognition and Brain Sciences Unit\, Dept of Clinical Neurosciences\, University of Cambridge\nSusan Kohlhaas (Director of Research\, Alzheimer’s Research UK)\nPeter Larsen (J&J Innovation) \n\n\nTime\n\nRegister here!
URL:https://www.milner.cam.ac.uk/event/cats-milner-series-june/
LOCATION:Cambridgeshire
END:VEVENT
END:VCALENDAR